Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Paroxysmal nocturnal haemoglobinuria: Which Medications Are Safest? (66 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

66 medications are used for Paroxysmal nocturnal haemoglobinuria, with 16,520 combined adverse event reports. The most reported drugs for Paroxysmal nocturnal haemoglobinuria are ECULIZUMAB and RAVULIZUMAB-CWVZ.

16,520
Total Reports
66
Drugs Used

All Medications for Paroxysmal nocturnal haemoglobinuria Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
ECULIZUMAB SOLIRIS 12,054 4,626 12,421 10.5%
RAVULIZUMAB-CWVZ - 2,175 551 1,663 5.4%
SOLIRIS - 1,478 227 838 9.5%
PEGCETACOPLAN Empaveli 559 84 252 6.1%
IPTACOPAN FABHALTA 291 23 88 4.9%
DANICOPAN Voydeya 89 7 27 4.8%
CYCLOSPORINE Verkazia 50 9,332 14,257 13.7%
RAVULIZUMAB Ultomiris 50 11 89 9.3%
CROVALIMAB-AKKZ - 36 4 24 10.5%
PREDNISOLONE Prednisolone Sodium Phosphate 17 13,159 32,883 16.3%
PREDNISONE prednisone 8 22,555 57,772 14.2%
DEFERASIROX Deferasirox 6 2,661 4,008 23.5%
METHYLPREDNISOLONE Medroloan II SUIK 5 12,828 26,552 20.1%

View all 66 drugs →

Most Reported Drugs for Paroxysmal nocturnal haemoglobinuria

#1 most reported
#2 most reported
#3 most reported